Investors

• President's Message
• Financial Results
• Investor Events
• Integrated Report
• Corporate Strategy
• ESG

• Nov. 21, 2022 Info(Updated) Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023 
• Nov. 21, 2022 Info(Updated) Notice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation System 
• Nov. 11, 2022 InfoSecond Quarter Financial Results
• Nov. 11, 2022 InfoNotice Concerning Recording Gain on Transfer of Shares and Revision to Financial Forecasts 
• Nov. 11, 2022 InfoNotice Regarding Share Repurchase and Cancellation of Treasury Shares 

View All

• Management Policies
  • President's Message
  • Corporate Philosophy
  • Corporate Strategy
  • Directors and Executive Officers
  • Articles of Incorporation
  • Disclosure Policy
  • Business Risks
  • Company Presentation PDF
• IR Library
  • Financial Results
  • Investor Events
  • Corporate Disclosure
  • Securities Report
  • Integrated Report
  • Olympus Medical Business
• Stock Information
  • Shareholders' Information
  • General Meeting of Shareholders
  • Shareholder Returns
  • Corporate Bonds and Ratings
  • Analyst Coverage
• Financial Data
  • Annual Data
  • Quarterly Data
  • Download Financial Data
• ESG
  • Olympus Group ESG
  • Environment
  • Social
  • Governance
• About Us
  • Olympus’ Value Creation Model
  • Fact Sheet
  • About Olympus

Annual Schedule

* The schedule may be subject to change.

• Internet IR Commendation Award 2021 by Daiwa Investor Relations Co. Ltd.
• AAA Website, All Japanese Listed Companies' Website Ranking 2021, Overall and Sector by Nikko Investor Relations Co.,Ltd.